Polycystic Ovary Syndrome: Pathophysiology, Presentation and Treatment a Mini-Review Article

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745-2749.10.1210/jc.2003-032046Search in Google Scholar

2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84:4006–401110.1210/jcem.84.11.6148Search in Google Scholar

3. Lukola, R. Punnonen, Interaction of serine protease inhibitors and substrates with human uterine estrogen receptor, Biochem. Biophys. Res. Commun. 108 (1982) 822–827. doi:10.1016/0006-291X(82)90903-2.10.1016/0006-291X(82)90903-2Search in Google Scholar

4. N. Xu, S. Kwon, D.H. Abbott, D.H. Geller, D.A. Dumesic, R. Azziz, X. Guo, M.O. Goodarzi, Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys, PLoS One. 6 (2011). doi:10.1371/journal.pone.0027286.10.1371/journal.pone.0027286320863022076147Search in Google Scholar

5. M. Kokosar, A. Benrick, A. Perfilyev, R. Fornes, E. Nilsson, M. Maliqueo, C.J. Behre, A. Sazonova, C. Ohlsson, C. Ling, E. Stener-Victorin, Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome, Sci. Rep. 6 (2016). doi:10.1038/srep22883.10.1038/srep22883479163226975253Search in Google Scholar

6. J. Boberg, C. Taxvig, S. Christiansen, U. Hass, Possible endocrine disrupting effects of parabens and their metabolites., Reprod. Toxicol. 30 (2010) 301–12. doi:10.1016/j.reprotox.2010.03.011.10.1016/j.reprotox.2010.03.01120381602Search in Google Scholar

7. S. Özen, Ş. Darcan, Effects of environmental endocrine disruptors on pubertal development., J. Clin. Res. Pediatr.Endocrinol. 3 (2011) 1–6. doi:10.4274/jcrpe.v3i1.01.10.4274/jcrpe.v3i1.01306530921448326Search in Google Scholar

8. Konieczna, A. Rutkowska, D. Rachoń, Health risk of exposure to Bisphenol A (BPA)., Rocz. Państwowego Zakładu Hig. 66 (2015) 5–11. http://www.ncbi.nlm.nih.gov/pubmed/25813067 (accessed August 5, 2015).Search in Google Scholar

9. G.O. Noonan, L.K. Ackerman, T.H. Begley, Concentration of bisphenol A in highly consumed canned foods on the U.S. market., J. Agric. Food Chem. 59 (2011) 7178–85. doi:10.1021/jf201076f.10.1021/jf201076f21598963Search in Google Scholar

10. S. De Coster, N. van Larebeke, Endocrine-disrupting chemicals: associated disorders and mechanisms of action., J. Environ. Public Health. 2012 (2012) 713696. doi:10.1155/2012/713696.10.1155/2012/713696344360822991565Search in Google Scholar

11. S. Patel, Fragrance compounds: The wolves in sheep’s clothings, Med. Hypotheses. 102 (2017) 106–111. doi:10.1016/j.mehy.2017.03.025.10.1016/j.mehy.2017.03.02528478814Search in Google Scholar

12. Y.A. Lee, E.J. Cho, T. Yokozawa, Protective effect of persimmon (Diospyros kaki) peel proanthocyanidin against oxidative damage under H2O2-induced cellular senescence., Biol. Pharm. Bull. 31 (2008) 1265–9. http://www.ncbi.nlm.nih.gov/pubmed/18520066 (accessed October 7, 2016).10.1248/bpb.31.126518520066Search in Google Scholar

13. S. Patel, S. Patel, Analysis of Ebola virus polymerase domains to find strain-specific differences and to gain insight on their pathogenicity, VirusDisease. 27 (2016) 242–250. doi:10.1007/s13337-016-0334-8.10.1007/s13337-016-0334-8539469828466035Search in Google Scholar

14. E.Y. Roh, J.H. Yoon, E.Y. Song, J.J. Kim, K.R. Hwang, S.H. Seo, S. Shin, Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women, J. Assist. Reprod. Genet. 34 (2017) 139–147. doi:10.1007/s10815-016-0824-z.10.1007/s10815-016-0824-z533097927796807Search in Google Scholar

15. J.B. Wu, J.F. Zhai, J. Yang, Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk, Genet. Mol. Res. 15 (2016). doi:10.4238/gmr15048570.10.4238/gmr1504857028081274Search in Google Scholar

16. S. Dasgupta, P.V.S. Sirisha, K. Neelaveni, K. Anuradha, G. Sudhakar, B.M. Reddy, Role of luteinizing hormone β-subunit gene variants among South Indian women with polycystic ovary syndrome, Gene. 494 (2012) 51-56. doi:10.1016/j.gene.2011.11.054.10.1016/j.gene.2011.11.05422209983Search in Google Scholar

17. Mohamed-Hussein ZA, Harun S. Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data. Theor Biol Med Model. 2009;6(1):18.10.1186/1742-4682-6-18274364919723303Search in Google Scholar

18. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19:41–47.10.1093/humrep/deh09814688154Search in Google Scholar

19. Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam Criteria. J Clin Endocrinol Metab. 2006;91:786-789.10.1210/jc.2005-250116418209Search in Google Scholar

20. Apter D, Bützow T, Laughlin GA, Yen SS. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab. 1994;79(1):119–12510.1210/jcem.79.1.8027216Search in Google Scholar

21. Lizneva D, Kirubakaran R, Mykhalchenko K, Suturina L, Chernukha G, Diamond MP, Azziz R. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. Fertil Steril. 2016;106(6):1510–1520.e2.10.1016/j.fertnstert.2016.07.112127530062Search in Google Scholar

22. Pache TD, Fauser BC. Polycystic ovaries in female-tomale transsexuals. Clin Endocrinol (Oxf). 1993;39(6):702–703.Search in Google Scholar

23. Anderson RA, McLaughlin M, Wallace WH, Albertini DF, Telfer EE. The immature human ovary shows loss of abnormal follicles and increasing follicle developmental competence through childhood and adolescence. Hum Reprod. 2014;29(1):97–106.10.1093/humrep/det388386089524135076Search in Google Scholar

24. Gaytan F, Morales C, Leon S, Garcia-Galiano D, Roa J, Tena-Sempere M. Crowding and follicular fate: spatial determinants of follicular reserve and activation of follicular growth in the mammalian ovary. PLoS One. 2015;10(12):e0144099. [10.1371/journal.pone.0144099467164626642206Search in Google Scholar

25. Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O. Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod. 2006;21(9):2223–2227.10.1093/humrep/del16516720622Search in Google Scholar

26. Xu J, Bishop CV, Lawson MS, Park BS, Xu F. Anti- Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates. Hum Reprod. 2016;31(7):1522–1530.10.1093/humrep/dew100490188227165618Search in Google Scholar

27. Dumont A, Robin G, Dewailly D. Anti-Müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome. Curr Opin Endocrinol Diabetes Obes. 2018;25(6):377–384.10.1097/MED.000000000000044530299432Search in Google Scholar

28. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J, Bondy CA. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab. 1998;83(7):2479–2485.10.1210/jcem.83.7.49179661631Search in Google Scholar

29. Harlow CR, Shaw HJ, Hillier SG, Hodges JK. Factors influencing follicle-stimulating hormone-responsive steroidogenesis in marmoset granulosa cells: effects of androgens and the stage of follicular maturity. Endocrinology. 1988;122(6):2780–2787.10.1210/endo-122-6-27803131124Search in Google Scholar

30. Sen A, Hammes SR. Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol. 2010;24(7):1393–1403.10.1210/me.2010-0006290390420501640Search in Google Scholar

31. Кeppesen JV, Kristensen SG, Nielsen ME, Humaidan P, Dal Canto M, Fadini R, Schmidt KT, Ernst E, Yding Andersen C. LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. J Clin Endocrinol Metab. 2012;97(8):E1524–E1531.10.1210/jc.2012-1427341027922659248Search in Google Scholar

32. Kristensen SG, Mamsen LS, Jeppesen JV, Bøtkjær JA, Pors SE, Borgbo T, Ernst E, Macklon KT, Andersen CY. Hallmarks of human small antral follicle development: implications for regulation of ovarian steroidogenesis and selection of the dominant follicle. Front Endocrinol (Lausanne). 2018;8:376.10.3389/fendo.2017.00376577035529375481Search in Google Scholar

33. Franks S, Hardy K. Androgen action in the ovary. Front Endocrinol (Lausanne). 2018;9:452.10.3389/fendo.2018.00452609702730147675Search in Google Scholar

34. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, Franks S. Formation and early development of follicles in the polycystic ovary. Lancet. 2003;362(9389):1017–1021.10.1016/S0140-6736(03)14410-8Search in Google Scholar

35. Maciel GA, Baracat EC, Benda JA, Markham SM, Hensinger K, Chang RJ, Erickson GF. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(11):5321–5327.10.1210/jc.2004-064315531477Search in Google Scholar

36. Homer MV, Toloubeydokhti T, Lawson MA, Garzo G, Duleba AJ, Chang RJ. Individual 17- hydroxyprogesterone responses to hCG are not correlated with follicle size in polycystic ovary syndrome. J Endocr Soc. 2019;3(4):687–698.10.1210/js.2018-00339641141630918916Search in Google Scholar

37. Richards JS, Ren YA, Candelaria N, Adams JE, Rajkovic A. Ovarian follicular theca cell recruitment, differentiation, and impact on fertility: 2017 update. Endocr Rev. 2018;39(1):1–20.10.1210/er.2017-00164580709529028960Search in Google Scholar

38. Gilling-Smith C, Willis DS, Beard RW, Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab. 1994;79(4):1158–1165.10.1210/jcem.79.4.7962289Search in Google Scholar

39. Gilling-Smith C, Story H, Rogers V, Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf). 1997;47(1):93–99.10.1046/j.1365-2265.1997.2321049.x9302378Search in Google Scholar

40. Crawford TJ, Crowther CA, Alsweiler J, Brown J. Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. Cochrane Database of Systematic Reviews. 2015 DOI: 10.1002/14651858.CD011507.pub2.10.1002/14651858.CD011507.pub2659982926678256Search in Google Scholar

41. Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G, et al. Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocr Pract. 2002;8:417–23.10.4158/EP.8.6.41715251831Search in Google Scholar

42. Genazzani AD, Santagni S, Rattighieri E, Chierchia E, Despini G, Marini G, et al. Modulatory role of D-chiroinositol (DCI) on LH and insulin secretion in obese PCOS patients. Gynecol Endocrinol. 2014;30:438–43.10.3109/09513590.2014.89732124601829Search in Google Scholar

43. La Marca A, Grisendi V, Dondi G, Sighinolfi G, Cianci A. The menstrual cycle regularization following Dchiro- inositol treatment in PCOS women: A retrospective study. Gynecol Endocrinol. 2015;31:52-6.10.3109/09513590.2014.96420125268566Search in Google Scholar

44. Piomboni P, Focarelli R, Capaldo A, Stendardi A, Cappelli V, Cianci A, et al. Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: The effect of inositol and metformin. J Assist Reprod Genet. 2014;31:1269-7610.1007/s10815-014-0307-z417140825113619Search in Google Scholar

45. Jamilian M, Mansury S, Bahmani F, Heidar Z, Amirani E, Asemi Z. The effects of probiotic and selenium cosupplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. J Ovarian Res. 2018 Sep 14;11(1):80.10.1186/s13048-018-0457-1613774730217229Search in Google Scholar

46. Dastorani M, Aghadavod E, Mirhosseini N, Foroozanfard F, Zadeh Modarres S, Amiri Siavashani M, Asemi Z. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Reprod Biol Endocrinol. 2018 Oct 4;16(1):94. doi: 10.1186/s12958-018-0413-3.10.1186/s12958-018-0413-3617274530286768Search in Google Scholar

47. Kazemi M, McBreairty LE, Chizen DR, Pierson RA, Chilibeck PD, Zello GA. A Comparison of a Pulse- Based Diet and the Therapeutic Lifestyle Changes Diet in Combination with Exercise and Health Counselling on the Cardio-Metabolic Risk Profile in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial. Nutrients. 2018 Sep 30;10(10):1387.10.3390/nu10101387621286730274344Search in Google Scholar

48. Arentz S, Smith CA, Abbott J, Fahey P, Cheema BS, Bensoussan A. Combined Lifestyle and Herbal Medicine in Overweight Women with Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial. Phytother Res. 2017 Sep;31(9):1330-1340. doi: 10.1002/ptr.5858.10.1002/ptr.5858559998928685911Search in Google Scholar

49. Borzoei A, Rafraf M, Asghari-Jafarabadi M. Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome. Asia Pac J Clin Nutr. 2018;27(3):556-563. doi: 10.6133/apjcn.062017.13.Search in Google Scholar

50. Pedersen AJT, Stage TB, Glintborg D, Andersen M, Christensen MMH. The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial. Basic Clin Pharmacol Toxicol. 2018 Feb;122(2):239-244. doi: 10.1111/bcpt.12874.10.1111/bcpt.1287428834135Search in Google Scholar

51. Nordio M, Basciani S, Camajani E. The 40:1 myoinositol/ D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5512-5521. doi: 10.26355/eurrev_201906_18223.Search in Google Scholar

52. Ostadmohammadi V, Jamilian M, Bahmani F, Asemi Z. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. J Ovarian Res. 2019 Jan 21;12(1):5. doi: 10.1186/s13048-019-0480-x.10.1186/s13048-019-0480-x634018430665436Search in Google Scholar

53. Javed Z, Papageorgiou M, Deshmukh H, Kilpatrick ES, Mann V, Corless L, Abouda G, Rigby AS, Atkin SL, Sathyapalan T. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. Nutrients. 2019 Jan 17;11(1):188. doi: 10.3390/nu11010188.10.3390/nu11010188635630930658483Search in Google Scholar

54. Wang QY, Song Y, Huang W, Xiao L, Wang QS, Feng GM. Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial. Chin Med J (Engl). 2016 Apr 20;129(8):883-90. doi: 10.4103/0366-6999.179783.10.4103/0366-6999.179783483152027064030Search in Google Scholar

55. Jensterle M, Kravos NA, Goričar K, Janez A. Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial. BMC Endocr Disord. 2017 Jan 31;17(1):5. doi: 10.1186/s12902-017-0155-9.10.1186/s12902-017-0155-9528683728143456Search in Google Scholar

56. Liang R, Liu Z, Li P, Fan P, Xu L, Sun X, Peng J, Peng X, Zhang M. Kuntai capsules improve glucolipid metabolism in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Medicine (Baltimore). 2019 Sep;98(39):e16788. doi: 10.1097/MD.0000000000016788.10.1097/MD.0000000000016788677538231574794Search in Google Scholar